Business, energy, technology, markets and global industry news from Business News Today

Phase 3 oncology trials

PharmaDeviceNews Phase 3 oncology trials
Representative image of oncology researchers reviewing tumor imaging and clinical trial data, reflecting Immunome’s Phase 3 RINGSIDE results for varegacestat in adults with progressing desmoid tumors.
Pharma & Biotech

Why Immunome’s RINGSIDE data may reset expectations in desmoid tumor treatment

Discover how Immunome’s Phase 3 RINGSIDE data could reshape desmoid tumor treatment and gamma secretase inhibitor competition.

Read More
Pharma & Biotech

How PDS0101 patent coverage reshapes competitive risk in HPV16 positive head and neck cancer development

PDS Biotechnology strengthens PDS0101 patent protection as Phase 3 strategy evolves. Discover what this changes for immunotherapy competition.

Read More